PARP1 inhibitor olaparib (Lynparza) exerts synthetic lethal effect against ligase 4-deficient melanomas.
scientific article published on 27 September 2016
Author/s
author: Malgorzata Czyz, Monika Toma, Phil F Cheng, Mitchell P Levesque, Tomasz Sliwinski, Grażyna Hoser, Janusz Szemraj, Reinhard Dummer, Tomasz Skórski, Margaret Nieborowska-Skorska
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.